Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NSC Immunition is a dietary supplement developed by Nutritional Scientific Corporation (NSC) that features MG Beta 1,3/1,6 glucan as its primary active ingredient. Extracted from the cell walls of *Saccharomyces cerevisiae* (Baker's yeast), this purified isolate acts as a biological response modifier (BRM). It is designed to nutritionally support the immune system by activating and normalizing macrophages, dendritic cells, and other immune components. The product is marketed for a variety of health supports, including immune function, cardiovascular health, digestive health, and as a supportive aid for diabetes management. It is administered orally and is distinguished by its microparticulate formulation, which is intended to enhance potency compared to standard globular or reaggregated particulate glucan products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NSC Immunition.